Marijuana Blog

Despite Federal Law, Colorado Pot Shops Are Accepting Credit Cards

Category: News | Posted on Mon, May, 4th 2015 by THCFinder

While the cannabis industry has been touted as a “cash-only” enterprise since medical marijuana was first legalized in California nearly 20 years ago, recent reports indicate that the recreational sector has become fed up with handling massive stacks of cash and have since established a clever method for accepting credit cards payments.

Colorado pot shops have struggled for the larger part of the past year to adhere to federal statutes in an attempt to avoid provoking the DEA from sending in a team to shut them down. Part of this challenge has been conducting legal pot sales, which generate about $14 million per month, without the use of financial institutions.

Even though former U.S. Attorney General Eric Holder devised a set of rules in 2014 that would supposedly allow banks to work with marijuana businesses without the risk of prosecution, there have not been many willing to take a chance on these threatening endeavors because no changes to federal policy have been set in stone. Marijuana remains listed a Schedule I drug under the Controlled Substances Act, which has prevented retail pot shops and banks from getting into bed together. It seems that no one is interested in being sent to prison for money laundering.

However, a recent investigational report by FOX31 in Denver found that almost half of the state-licensed dispensaries (47 percent) operating in Colorado admit they are willing to accept MasterCard or Visa payments. This discovery does not suggest that financial institutions are now welcoming the cannabis industry with open arms, but rather, it seems that pot shops have devised a clever and seemingly legal scheme to throw the hounds of the drug war off their scent.

Read More:


Walking with Dabosaurs

Category: Concentrates | Posted on Sun, May, 3rd 2015 by THCFinder


Iowans rally for statewide marijuana legalization

Category: Legalization | Posted on Sun, May, 3rd 2015 by THCFinder

The daily pills 39-year-old Angel Francis-Kline has to take makes it hard for her to handle everyday life.

In a day, she can take between 12 to 16 pills to deal with her fibromyalgia, osteoarthritis, post-traumatic stress disorder, insomnia and early on-set menopause. The combination of her pills, like Cymbalta and Hydrocodone make her uncontrollably shake and have seizures, causing dangerous situations, especially when she's driving.

"It's living everyday in pain," Francis-Kline. said. "What they're making me take is poison."

One evening, after taking a hit of hash oil concentrate, commonly known as a "dab," Francis-Kline said she safely drove back home, felt no pain for over six hours and was able to fall asleep around midnight rather than the usual 3 a.m.

That's why she, along with dozens of other marijuana advocates, rallied across downtown, and stopped at the Iowa Capitol to share stories on why the legalization of marijuana needs to come to Iowa.

"I think it's ridiculous you can't treat yourself in a natural way," Francis-Kline said.

Read More:


California State Assembly Passes Medical Marijuana Organ Transplant Bill

Category: News | Posted on Sun, May, 3rd 2015 by THCFinder

california marijuanaThe California State Assembly passed AB 258, The Medical Cannabis Organ Transplant Act, yesterday by a vote of 52 to 8. The bill is authored by Assembly Member Marc Levine (D-San Rafael) and sponsored by Americans for Safe Access (ASA), the nation’s leading medical cannabis patients’ advocacy organization.

Medical cannabis patients in California are routinely removed from the organ transplant waiting list if they test positive for cannabis use – even legal doctor-recommended medical cannabis. However, medical research has shown that there is no significant difference in survival rates between medical cannabis patients and non-users who receive an organ transplant.

“Today, I am proud to stand with my Assembly colleagues in support of AB 258, a common sense measure that will protect the lives of legal medical cannabis patients,” said Assembly Member Marc Levine (D-San Rafael). “With this legislation, California can insure that its residents are provided a fair assessment of their eligibility as an organ transplant recipient.”

AB 258 will reduce unnecessary suffering and preventable death by prohibiting anyone in the organ transplant process from determining the recipient of an organ transplant based on the potential recipient’s legal medical cannabis use, unless a doctor has determined that medical cannabis use is clinically significant to the transplant process.

Norman Smith lawfully used medical cannabis as part of his treatment for liver cancer. He was removed from the Wait List by Cedars-Sinai Medical Center in Los Angeles after testing positive for medical cannabis use in 2011. Program policies required that he test negative for medical cannabis for six months before requesting a new place on the list. Sadly, Mr. Smith died before he could be placed back on the list, a tragic and avoidable loss of life.

Unfortunately, Mr. Smith is not alone. Toni Trujillo was denied a life-saving kidney transplant at Cedars-Sinai the following year based on her cannabis use, which the transplant center called “substance abuse.” Yami Bolanos, 58, is an eighteen-year liver transplant survivor, who was warned that she would be ineligible for a re- transplant by the same doctor at UCSF that recommended her medical cannabis use. Richard Hawthorne, another patient in need of a liver, was denied a transplant by Stanford Medical School last year, despite a friend offering to be a donor.

Read More:



Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
13.4 Miles Away | Los Angeles ,
15.4 Miles Away | Anaheim,
18.6 Miles Away | Long Beach,
November 26, 2015 | Category: Fun
November 26, 2015 | Category: News
November 26, 2015 | Category: Nugs
Mobile Apps
Copyright 2015
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us